The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using this form to ensure you don’t miss out on the most important healthtech news every week! Despite billion-dollar pandemic boost, AbCellera still seeks ‘escape velocity’ When AbCellera posted a nearly US$150-million annual loss at the end of 2023, it was an abrupt turn for a company seen as the lodestar of Vancouver’s biotech startup scene. For the previous two years, it had been awash in royalties from two COVID-19 therapies it co-developed in the midst of the pandemic. Yet despite the bleak earnings news and a languishing stock price, [CEO Carl] Hansen seems unfaze
Hence then, the article about h t the healthtech times abcellera plays the long game despite losses betakit was published today ( ) and is available oncanadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( H|T: The Healthtech Times – AbCellera plays the long game despite losses | BetaKit )